Avalo Therapeutics
AVTX
AVTX
43 hedge funds and large institutions have $88.5M invested in Avalo Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
40% less capital invested
Capital invested by funds: $148M → $88.5M (-$59.1M)
Holders
43
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$18.5M | |
| 2 | +$1.06M | |
| 3 | +$243K | |
| 4 |
Millennium Management
New York
|
+$168K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$136K |
Top Sellers
| 1 | -$60K | |
| 2 | -$60K | |
| 3 | -$56K | |
| 4 |
BlackRock
New York
|
-$42.8K |
| 5 |
SIM
Spark Investment Management
New York
|
-$38.8K |